Global and United States Pre-Clinical Imaging System Market Insights, Forecast to 2027

Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.

These days, many manufacturers provide multi-modal systems combining the advantages of anatomical modalities such as CT and MR with the functional imaging of PET and SPECT. As in the clinical market, common combinations are SPECT/CT, PET/CT and PET/MR.

Market Analysis and Insights: Global and United States Pre-Clinical Imaging System Market
This report focuses on global and United States Pre-Clinical Imaging System market.
In 2020, the global Pre-Clinical Imaging System market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Pre-Clinical Imaging System market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Pre-Clinical Imaging System Scope and Market Size
Pre-Clinical Imaging System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pre-Clinical Imaging System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Pre-Clinical Imaging System market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Standalone Imaging System
Multimodal Imaging System

Segment by Application
Clinical Research Organization (CRO)
Pharmaceutical Industries
Biotechnology Industries
Government and Private Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Bioscan
Bruker
PerkinElmer
Siemens Healthcare GmbH
Aspect Imaging
Thermo Fisher Scientific
MR Solutions
LI-COR
TriFoil Imaging